Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 6/20 | 0.33 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.33 |
| ▸ | PLAT | P00750 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526084 | 1.00 | POLB (0.36) | POLBGAAGRIN1GRIN2AGRIA2 | |
| Hydrochloric Acid SCHEMBL31753682 | 0.78 | POLB (0.42) | POLBGAAGRIN1GRIN2AGRIA2 | |
| Hydrochloric Acid SCHEMBL34467091 | 0.77 | POLB (0.46) | POLBGAAGRIN1GRIN2AGRIA2 | |
| Hydrochloric Acid SCHEMBL33527160 | 0.77 | POLB (0.46) | POLBGAAGRIN1GRIN2AGRIA2 | |
| Hydrochloric Acid SCHEMBL33526972 | 0.77 | POLB (0.42) | POLBGAAGRIN1GRIN2AGRIA2 | |
| Hydrochloric Acid SCHEMBL33527084 | 0.75 | POLB (0.39) | POLBGAAGRIN1GRIN2AGRIA2 | |
| Trifluoroacetic Acid SCHEMBL33527477 | 0.73 | POLB (0.41) | POLBGAAGRIN1GRIN2AGRIA2 | |
| Hydrochloric Acid SCHEMBL33526538 | 0.67 | LMNA (0.46) | POLBGAA | |
| Hydrochloric Acid SCHEMBL31752144 | 0.66 | LMNA (0.33) | POLBGRIN1GRIN2A | |
| Hydrochloric Acid SCHEMBL33527022 | 0.64 | TP53 (0.34) | POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | POLB 4745/4885GAA 2113/4885GRIN1 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.